Description
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide that acts as a selective agonist of the ghrelin receptor (GHSR-1a). Body Tech Peptides supplies it as a 5 mg lyophilized vial for laboratory research.
Product: Ipamorelin 5 mg
Form: Lyophilized powder
Category: Growth hormone signaling research
Research Context
Ipamorelin is used in preclinical models of growth hormone secretagogue receptor pharmacology, where its receptor selectivity makes it a useful comparison compound. These findings are experimental and do not establish safety or efficacy in humans.
Handling and Storage
Store the lyophilized vial frozen and protected from light. After reconstitution, keep the solution refrigerated at 2–8 °C and use it within the stability window validated in your own protocol; aliquot to avoid repeated freeze-thaw cycles.
Is Ipamorelin intended for human use?
No. This product is supplied strictly for laboratory research. It is not a medicine, is not intended for human or veterinary use, and Body Tech Peptides does not provide dosing or administration guidance.
What is Ipamorelin studied for in research?
Research has examined Ipamorelin in preclinical models of ghrelin receptor signaling and growth hormone secretion.
Is batch documentation available for this product?
Yes. The supplier’s certificate of analysis for your lot is available on request. See our Batch Documentation & Quality Records page.
Important Notice
For laboratory research use only. This product is not a medicine, has not been approved by the EMA, the FDA or any other medicines regulator, and is not intended to diagnose, treat, cure or prevent any disease. Not for human or animal consumption.
Documentation Status: The supplier’s certificate of analysis (COA) for the lot supplied is available on request; please quote the lot number printed on the vial. Supplier documentation is not represented as independent testing by Body Tech Peptides.
Only logged in customers who have purchased this product may leave a review.

Reviews
There are no reviews yet.